July 27, 2026 — RNews

#combination therapy — Monday, July 27, 2026 (1 items)

hot top new

← prev day next day →

0

Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer. (nature.com)

Mahadevan KK … Kalluri R Nature Communications 2026-07-27

#immunotherapy #t cell #pancreatic cancer #combination therapy #checkpoint-blockade